John C.K. Milligan IV Insider Trading $TXMD TherapeuticsMD, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John C.K. Milligan IV.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John C.K. Milligan IV. John C.K. Milligan IV is President/Secretary in TherapeuticsMD, Inc. ($COFF) and Secretary/CEO of subsidiary in TherapeuticsMD, Inc. ($TXMD).
John C.K. Milligan IV in TherapeuticsMD, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John C.K. Milligan IV: Secretary/CEO of subsidiary, President/Secretary
Holdings: 1,796,955 shares
Latest Transaction: May 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John C.K. Milligan IV in TherapeuticsMD, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Option Exercise | M | 0.00 | 103,500 | 0 | 207,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Sell | S | 1.04 | 44,252 | 46,022 | 1,752,703 | 1.8 M to 1.8 M (-2.46 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Buy | M | 0.00 | 103,500 | 0 | 1,796,955 | 1.7 M to 1.8 M (+6.11 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | X | 0.24 | 179,000 | 43,748 | 0 | |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 0 | 434.8 K to 0 (-100.00 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Payment of Exercise | F | 1.46 | 29,964 | 43,747 | 1,693,455 | 1.7 M to 1.7 M (-1.74 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | X | 0.24 | 179,000 | 43,748 | 1,723,419 | 1.5 M to 1.7 M (+11.59 %) |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 360,000 | 0 | 360,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 310,500 | 0 | 310,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 310,500 | 0 | 310,500 | |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.75 | 72,000 | 198,000 | 1,544,419 | 1.5 M to 1.5 M (+4.89 %) |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.75 | 72,000 | 198,000 | 1,544,419 | 1.5 M to 1.5 M (+4.89 %) |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.73 | 400,000 | 1,092,000 | 400,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.73 | 400,000 | 1,092,000 | 400,000 | |
| Aug 19 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.93 | 10,000 | 29,300 | 3,582,373 | 3.6 M to 3.6 M (+0.28 %) |
| Aug 14 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 3.16 | 15,000 | 47,400 | 3,572,373 | 3.6 M to 3.6 M (+0.42 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,127 | 13,145 | 0 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,127 | 13,145 | 0 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 129,127 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 129,127 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.64 | 129,127 | 469,635 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.64 | 129,127 | 469,635 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,127 | 13,145 | 1,601,546 | 1.5 M to 1.6 M (+8.77 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,127 | 13,145 | 1,601,546 | 1.5 M to 1.6 M (+8.77 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.75 | 129,000 | 483,750 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.75 | 129,000 | 483,750 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 258,127 | |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 387,127 | |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.57 | 129,000 | 589,530 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.98 | 129,000 | 642,162 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,128 | 13,145 | 516,127 | |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 645,255 | |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.03 | 129,128 | 650,030 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,128 | 13,145 | 1,601,547 | 1.5 M to 1.6 M (+8.77 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.89 | 129,000 | 630,294 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 774,255 | |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 903,255 | |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.99 | 129,000 | 643,581 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.82 | 129,000 | 621,651 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,032,255 | |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,157,255 | |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.37 | 125,000 | 671,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.33 | 125,000 | 666,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,282,255 | |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,407,255 | |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.76 | 125,000 | 719,625 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.95 | 125,000 | 743,125 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,532,255 | |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,657,255 | |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.78 | 125,000 | 847,000 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.78 | 125,000 | 847,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,782,255 | |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,907,255 | |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 434,814 | 0 to 434.8 K |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 0 | 434.8 K to 0 (-100.00 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.13 | 125,000 | 765,750 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.07 | 125,000 | 758,125 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 5.16 | 270,000 | 1,393,200 | 270,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 6.83 | 260,000 | 1,775,800 | 260,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 8.92 | 500,000 | 4,460,000 | 500,000 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.64 | 50,000 | 132,000 | 3,517,627 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 3.00 | 800,000 | 2,400,000 | 3,493,198 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.55 | 75,000 | 191,250 | 2,693,198 | |
| Apr 17 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.55 | 75,000 | 191,250 | 2,693,198 | |
| Mar 16 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.20 | 300,000 | 660,000 | 2,318,198 |
Page: 1